Nr 546 week 7 Study guides, Class notes & Summaries

Chamberlain NR 546 Week 7 ADHD Medication Table

NR 546 WEEK 7 ADHD Medication Table (Updated). Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulations), narcolepsy. Off-label for treatmentresistant depression. Enhancement DA and NE in certain areas of the brain (dorsolateral prefrontal cortex, medial prefrontal cortex). Primary target symptoms: concentration, attention span, motor hyperactivity,...

NR 546 Week 7 ADHD Medication Table Latest. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Indication (include approved ages) Attention deficit hyperactivity disorder (ADHD) in children and adults (approved ages vary base...

NR 546 Week 7 ADHD Medication Table Latest. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Indication (include approved ages) Attention deficit hyperactivity disorder (ADHD) in children and adults (approved ages vary base...

NR 546 WEEK 7 ADHD Medication Table. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediateacting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulatio...

NR 546 Week 7 Case Study: Child and Adolescent (Solved). Subjective Objective The client is a 7-year-old male accompanied by his mother and 9-year-old brother. Client’s Chief Complaints: “My son has endless energy, he can’t sit still. When he plays, he is too rough with other kids.” History of Present Illness This clint was previously diagnosed with attentiondeficit/hyperactivity disorder (ADHD). The school reports that he cannot stay seated, frequently calls out in class, is d...

Chamberlain NR 546 Week 7 Review powerpoint

Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediateacting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulations), narcolepsy. Off-label for trea...

NR 546 Week 1-7 Quiz’s | Midterm Exam Questions With Answers and Rationales 2024. In order to provide feedback on the weekly quizzes, I will provide rationale statements for the quiz questions. You will note that there are more than 5 listed this is because the quiz testbank is larger than 5 questions and the additional information can help you prepare for the final and direct your study.  The amygdala is associated with anxiety and perception of odors.  The hippocampus is involved...